Log In
BCIQ
Print this Print this
 

CR4056

  Manage Alerts
Collapse Summary General Information
Company Rottapharm Biotech s.r.l.
DescriptionImidazoline-2 (I2) binding site ligand
Molecular Target Imidazoline-2 receptor (IR2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat acute pain; Treat neuropathic pain; Treat osteoarthritis pain; Treat post-operative pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today